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ABSTRACT 
 
Epidemiological studies indicate that populations who consume 
foods rich in specific polyphenols have lower incidence of inflammatory 
diseases. In turn, Mediterranean diet, claimed for its several health 
benefits, provides a wide range of foods which are particularly enriched 
sources of polyphenols, some of which known for their anti-inflammatory 
properties. In this context, various herbs, vegetables and fruits, as well as 
fruit derivative products, such as wine and virgin olive oil, are believed to 
have an important role preventing and/or ameliorating inflammatory 
conditions through diet. Additionally, they are strong candidates for anti-
inflammatory drugs.  
In general, the anti-inflammatory properties of polyphenols involve 
the modulation of pro-inflammatory gene expression including 
cyclooxygenase, lipoxygenase, nitric oxide synthases and several pivotal 
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cytokines such as TNF-α, interleukin-1 (IL-1) and interleukin-6 (IL-6), 
mainly by acting through nuclear factor-κB (NF-κB) and mitogen-
activated protein kinase (MAPK) signaling. 
Since inflammation is a phenomenon present in many chronic 
diseases including cancer, diabetes, obesity, and cardiovascular disease, 
the modulation of the aforementioned markers by polyphenols may 
positively contribute for the prevention and/or amelioration of these 
diseases. 
The present chapter focus various edible Mediterranean typical foods 
known for their anti-inflammatory properties, as well as the main pheno-
lic constituents associated to the protection process and their underlying 
mechanisms of action. 
 
Keywords: Mediterranean Diet; Anti-inflammatory; Polyphenols; Virgin olive 
oil; Wine; Spices; Herbs; Vegetables; Fruits 
 
 
INTRODUCTION 
 
The Mediterranean Diet (MDiet), a modern nutritional recommendation 
inspired by the traditional dietary patterns of Mediterranean basin located 
countries, including Croatia, Cyprus, Greece, Italy, Morocco, Portugal and 
Spain, was recognized in 2013 by UNESCO as an Intangible Cultural Heritage 
[1]. 
MDiet is known to contribute for an adequate consumption of nutrients 
and has been closely associated to the low occurrence of chronic diseases such 
as cancer, diabetes, obesity, and cardiovascular disease. One of the key 
elements for the claimed benefits of this diet is its wide range of fruits and 
vegetables, as well as fruit derivative products, such as wine and virgin olive 
oil (VOO). 
Indeed, MDiet contains an ample source of components of proved health 
benefit effects, among which omega-3 fatty acids, oleic acid and phenolic 
compounds hold a prominent place [2, 3]. 
In particular, phenolic compounds have been shown to interact with a 
wide spectrum of molecular targets involved in the cell signaling machinery, 
including those of the inflammatory processes. In this scenario, phenolic 
compounds are not only able to rescue oxidative reactive species, as they also 
modulate the activity of pro-inflammatory enzymes and that of signaling 
proteins and transcription factors [4, 5]. 
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The present review focus on typical MDiet phenolic compounds and their 
target mechanisms of the inflammatory process. 
 
1. THE INFLAMMATORY PROCESS 
 
The inflammatory process is a complex and coordinated immunological 
response of the organism to a viral or bacterial infection, or to an internal 
injury [2]. This compromises two distinct, yet highly related and dependent 
processes: the innate or unspecific immunity and an acquired, or specific 
immunity. The first is fast and is activated by a large number, though limited, 
stimuli. It is present in all individuals and it is composed of physical, chemical 
and biological barriers, specialized cells and soluble molecules. In turn, the 
activation of adaptive immune system causes the increment of microbial-
specific leukocytes, a process that is highly effective and specific, but that 
takes days to fully develop [6]. 
Table 1 resumes the cells and molecules of the innate system. Both 
circulating cells i.e., those that are found in blood circulation and then migrate 
to the inflammation site via the action of several mediators (e.g. monocytes, 
which later differentiate in macrophages) and residing cells, i.e., cells that are 
found in the extracellular matrix of the organism and are activated the 
presence of an injury (e.g. macrophages, mast cells and dendritic cells), 
express in their surface Pattern Recognition Receptors (PRR). The latter detect 
both exogenous and endogenous antigens. In particular, the exogenous 
antigens (e.g. nucleic acids, carbohydrates) from pathogenic agents are 
detected by Pathogen-Associated Molecular Patterns (PAMPs) and the 
endogenous ones from injured or damaged cells are detected by the Damage-
Associated Molecular Patterns (DAMPs) [7]. 
When activated, the PRRs oligomerize and form large complexes 
composed of various subunits. Those complexes then initiate signaling 
cascades that trigger the production of several factors, causing the recruitment 
of specific leukocytes (adaptive immune response) [6]. 
Once the signaling cascade is activated, there are several changes in the 
vasculature of the injured/damaged tissue which end up in increased blood 
flow and serum proteins in the extracellular area. These events cause the 
visible hallmarks of inflammation, i.e., calor (warmth), rubor (redness), tumor 
(swelling) and dolor (pain) [2]. 
The intensity of those hallmarks can be increased by the acquired immune 
system cells, though primary signals that start and resolve them are associated 
with the innate immune system [6]. 
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The signaling cascade comprises different steps: the presence of infla-
mmation inducers; the recognition of said inducers; a signal transduction that 
leads to the release of pro-inflammatory cytokines; the activation of inflamma-
tory effectors. These effectors will then cause the polarization of the 
inflammation, i.e, the activation of T cells, which is followed by the resolution 
of the inflammation.  
 
Table 1. Innate Immune System Molecules and Cells 
 
Innate Immune System Cells and Molecules 
Cell 
Phagocytic 
Dendritic Cells 
Macrophages 
Neutrophils 
Natural Killer (NK) Cells 
 
Mast cells 
Basophils 
Eosinophils 
Molecules 
Complement 
Acute Phase Proteins 
Inflammatory Mediators 
Cytokines 
Eicosanoids 
Chemokines 
 
There are two stages of inflammatory response: the acute and the chronic 
inflammation. The acute phase of inflammation starts immediately upon injury 
and rapidly turns severe but notably, it lasts only for a short period and is 
usually beneficial to the host, ending up in the resolution of the inflammatory 
event. However, in some cases the inflammation lasts longer than it should and 
the chronic inflammation is settled, thus predisposing the host to various 
inflammatory pathologies [2]. 
All the events of acute and/or chronic inflammation are mediated and 
controlled by chemical mediators which are produced by both residing and 
circulating immune system cells, after a recognition of a pathogenic or injury 
agent. 
Mediators have a very short life and are highly regulated by several 
mechanisms (e.g. enzymatic degradation) however, before being destroyed, 
mediators exercise their activity through direct binding to receptors on 
different cell types or, alternatively, via a direct action that does not require  
binding to receptors [8]. 
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Undoubtedly, tumor necrosis factor- (TNF-) is one of the most 
important regulatory mediators of the inflammatory cascade. This cytokine 
(i.e., peptide with low molecular weight that isproduced by several immune 
system cells in response to a stimulus) is a transmembrane protein of 26 kDa. 
Notably, this is released in its active form (17 kDa), in a process that is strictly 
regulated by an enzyme called TNF- activating converting enzyme (TACE, a 
disintegrin metalloproteinase that is bound to the membrane) [9]. 
Due to the central figure of TNF-, several inflammatory diseases (e.g. 
asthma, cystic fibrosis, rheumatoid arthritis, atherosclerosis and osteoporosis) 
start to manifest when this is deregulated. 
The pro-inflammatory effects of TNF- are mainly due its ability to 
activate NF-κB [10], i.e., a transcription factor that is present in all mammalian 
cells. This pathway is activated upon linkage of TNF- to the TNF-Receptor 1 
(also found in all cell types of the organism), which has a cytoplasmic “death 
domain” that recruits several proteins (Figure 1). When the recruited protein is 
TRADD (TNF-receptor associated death domain), the latter further recruits 
TRAF2 (TNF-receptor-associated factor). The TRADD-TRAF2 complex then 
activates IKK (IκBα Kinase), in a process mediated by the receptor-interacting 
protein (RIP) and in turn, this phosphorylates IκB. Phosphorylation of IκB 
causes it to be a target for ubiquitation. This pathways destroys IκBα and 
releases NF-κB, allowing it to bind DNA’s promoter or enhancer regions, 
causing an increase in the expression of some genes, like TNF- itself and 
others that play key roles in inflammation, such as cyclooxygenase-2 (COX-
2), 5-lipo-xygenase (5-LOX), inducible nitric oxide synthase (iNOS), cell-
adhesion molecules (CAMs) and other inflammatory cytokines [9]. 
Notably, COX-2 and 5-LOX are pivotal players in the arachidonic acid 
pathway, respectively controlling the biosynthesis of pro-inflammatory 
eicosanoids and of leukotrienes (considered as potent mediators locally 
released at the inflammation site by leukocytes and other 5-LOX expressing 
cells) [11]. The up-regulation of iNOS deeply increases the production of NO 
in cells, mainly in macrophages and endothelial cells. This agent is cytotoxic 
(thus killing foreign agents) and is also closely associated to vasodilatation 
during inflammation [8]. Moreover, CAMs, namely intercellular adhesion 
molecule 1 (ICAM-1), vascular adhesion molecule 1 (VCAM-1) and selectins 
[4, 9], regulate the binding of cells to extracellular matrix, to endothelial cells 
and to other cells [9, 12]. 
In turn, the activation of TRADD-TRAF2 by TNF- can also promote the 
recruitment of other proteins which contribute to inflammation through regu-
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lation and/or activation of a series of cell-signalling mediators, including the 
JNK (c-Jun amino terminal kinase), p38MAPK (p38 mitogen activated protein 
kinase), AKT kinase AP-1 (Activator protein-1) and p44/p42MAPK (ERK1/2) 
[9]. 
We must also remark that there are many other important cytokines 
besides TNF-. Indeed, the inflammatory process encloses more than 100 
different types of cytokines. TNF- and other pro-inflammatory cytokines like 
IL-1β, IL-6, IL-18, Interferon-γ (INF-γ)) are up-regulated in the inflamed 
organs/tissues together with some anti-inflammatory cytokines (e.g. IL-10, 
Insuline-like growth factor and insulin receptor activation) which inhibit the 
production of inflammation [9, 13]. 
 
 
Figure 1. TNF-α and NF-κB pathways in the inflammatory process. TACE (TNF-
activating converting enzyme) activity causes the release of the membrane-bound 
TNF-α, thus becoming soluble. TNF-α then binds to the TNFR (TNF Receptor) which 
causes the recruiting of TRADD (TNF-receptor-associated death domain), RIP 
(Receptor-interacting protein) and TRAF2 (TNF-receptor-associated factor). This 
complex activates IKK (IκBα Kinase) that ultimately phosphorylates IκBα and marks 
it to be degraded via the proteasome pathway. This degradation frees NF-κB, allowing 
it to migrate to the nucleus where it binds to specific inflammatory genes increasing 
their expression. NF-κB can also be activated by other pathways, namely AKT, 
ERK1/2, c-Jun and p38MAPK. 
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2. WINE 
 
Moderate red wine consumption, in particular at meals, is one of the main 
labels of MDiet. Indeed, high fat consumption yet low incidence of coronary 
heart disease is a reality found in southern France known as the “French 
paradox”, which places wine in a high level of scientific interest [14]. 
At present, it is believed that polyphenols are key agents in the protective 
properties of this alcoholic beverage [15]. White and, in particular the red 
wines, are rich sources of polyphenolic compounds (see Table 2) with 
remarkable antioxidant and anti-inflammatory properties. 
 
Table 2. Relative Phenolic Content of Red Wine 
 
Phenolic group Compound Content
*
 (mg/L) 
Flavonols 
Quercetin 127.8 
Kaempferol 1.0 
Myricetin 12.3 
Rutin 7.4 
Anthocyanins 
Malvidin-3-glucoside 46.7 
Peonidin-3-glucoside 19.0 
Petunidin-3-glucoside 21.0 
Cyanidin-3-glucoside 38.0 
Delphinidin-3-glucoside 10.9 
Flavan-3-ols 
Catechin 94.0 
Epicatechin 44.3 
Procyanidins 215.0 
Hydrobenzoic acids 
Protocatechuic acid 88.0 
Gallic acid 63.8 
Syringic acid 11.5 
Hydroxycinnamic acids 
Caffeic acid 8.7 
Caftaric acid 80.9 
Coutaric acid 52.2 
Ferulic acid 10.9 
p-Coumaric acid 4.7 
Stilbenes Resveratrol 1.2 
Table adapted from Beer et al. [16]. 
*
These are average values that can vary depending of the wine brand and aging time. 
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Anti-inflammatory properties of red wine have been proved in an in vivo 
human model of coronary high-risk volunteers. In more detail, Chiva-Blanch 
et al. [17] showed that the administration of red wine and dealcoholized red 
wine (both from Merlot grapes) to the volunteers reduced several serum 
inflammatory markers. Both samples significantly reduced the levels of 
monocyte chemotactic protein (MCP)-1, the cytokine IL-6 and IL-16, the 
adhesion molecules ICAM-1 and VCAM-1 and of CD40 antigen. While 
decrement of E-selectin and increment of IL-10 were more pronounced on 
patients consuming dealcoholized wine, reduction of macrophage-derived 
chemokine was observed in patients administrated with normal wine, 
suggesting that either ethanol and polyphenols contribute to the wine´s anti-
inflammatory properties [17]. 
The antioxidant and anti-inflammatory properties have also been 
demonstrated for wine´s phenolic-enriched extracts. In accordance to the 
greater phenolic content of red wines regarding that of white wines, 
Xanthopoulou et al. [14] proved that the antioxidant and anti-inflammatory 
properties of phenolic extracts obtained from red wine conferred superior 
protection against lipid peroxidation and lipoxygenase activity. Moreover, it 
has been observed that lipopolysaccharide (LPS)-stimulated human colon-
derived CCD-18Co fibroblast cells treated with red wine phenolic extracts 
(from Lenoir grapes) significantly reduced the gene expression of pro-
inflammatory cytokines IL-6 and TNF-α. Likewise, the red wine extract 
treatment also reduced the activation of NF-κB, which is responsible for the 
transcription of those same genes [18]. 
Figure 2 is a simplified representation of the multiple inflammatory 
cellular targets of wine phenolics. A description of these effects for individual 
phenolics is further detailed hereinafter. 
Among the phenolic compounds of the red wine, malvidin, mostly in its 3-
O-β-glucoside form, is the most abundant and also responsible for the red 
wine´s color [19]. According to literature data, this anthocyanin interacts in 
distinct inflammatory processes, capable to directly impair several 
inflammatory mediators. 
On CD23-stimulated human monocyte-derived macrophages, the treat-
ment with malvidin-3-O-β-glucoside (50μM) dramatically down-regulated IL-
6 secretion (from 62±24 to 34±9 pg/ml) as well as the gene expression of 
TNF-α, MIP-α (macrophage inflammatory protein), IL-1and IL-8 (35-88% 
inhibition) [20].Moreover, as demonstrated by Descendit et al. [20], this 
phenolic is able to reduce the iNOS-mediated NO production by decreasing 
transcription of iNOS encoding mRNA [20]. Additionally, the aglycone form 
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of this phenolic was shown to block the p65-subunit of NF-κB (necessary for 
activation of the transcription factor), as well as the binding of the activated 
NF-κB to the correspondent DNA binding site [21]. 
Besides, Bognar et al. [21] documented that malvidin (at 50 µM) impaired 
the MAPK signaling pathway, per order of effectiveness ERK1/2<p38-
MAPK<JNK, and enhanced MAPK phosphatase-1 mRNA and protein expre-
ssion thus down-regulating every MAPK signaling steps. 
Cyanidin and quercetin are also major phenolics in red wine [19] that can 
contribute for the wine´s anti-inflammatory effects. The fact that the two 
compounds inhibit monocyte adhesion to TNF-α-induced HAEC cells suggest 
that these have anti-atherogenic properties. Both cyanidin and quercetin were 
shown to effectively attenuate VACM-1, IL-8 and CD40 expression while 
quercetin was also able to significantly attenuate ICAM-1 and E-selectin 
expressions [22]. 
Quercetin has also been demonstrated to exhibit potent inhibitory effects 
on the three groups of central inflammatory enzymes, i.e., iNOS, COX and 
LOX, thus causing a significant reduction on both mRNA and protein 
expression of either iNOS and COX-2 and consequently, on their derivative 
products (NO and prostaglandins PGE2 respectively) [23, 24]. 
Besides, other markers of inflammation, including TNF-α, IL-1β, IL-6 and 
MCP-1 (also involved in atherogenic processes), have likewise been described 
to be effectively inhibited by quercetin on several activated macrophages such 
as RAW 264.7 or PBMC macrophages [4, 23]. 
Additionally, both quercetin and cyanidin notably reduced NF-κB 
expression and its binding to the DNA, as well as the ERK1/2 and p38-MAPK 
expression, hence impairing both NF-κB and MAPK signaling pathways on 
stimulated HAEC cells [22, 25]. 
Other wine´s minor phenolic compounds have also been reported for their 
anti-inflammatory capacities. Examples of these are myricetin, kaempferol, 
catechins, ferulic acid, coumaric acid and many others which have been 
described for their ability to inhibit and interfere with many inflammation 
mediators, i.e. COX, LOX and iNOS enzymes, NF-κB and MAPK signaling 
pathways and even enhance anti-inflammatory cytokines such as IL-10 [4]. 
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P - phosphorylated. 
Figure 2. Wine polyphenols may impair inflammation by blocking activation of 
mitogen-activated protein kinases (MAPKs) and IκB kinases (IKK), preventing their 
signaling pathways progression and activation of nuclear factor-kappa B (NF-κB) and 
activator protein (AP)-1. Wine polyphenols may prevent inflammatory tumor necrosis 
factor alpha (TNF-α)/TNF receptor (TNFR) or lipopolysaccharide (LPS)/toll-like 
receptor (TLR) signaling to IKK inhibiting the IκBα phosphorylation and further 
degradation, thus preventing the p50 and p65 dimers from complexing and forming the 
NF-κB. Likewise, MAPK kinases signaling and their down-stream, extracellular 
signal-related kinase (ERK) and terminal kinases JNK and p38 are also blocked, 
preventing the phosphorylation and further complexation of c-JUN and c-FOS in AP-1. 
As these two pivotal inflammatory transcription factors are inactivated, the 
transcription of inflammatory genes [e.g., TNF-α, IL-6, IL-8, IL-1β, and monocyte 
chemoattractant protein (MCP)-1] no longer occurs, thus ceasing the inflammation 
progress. 
 
 
Resveratrol 
 
Notably, resveratrol (another minor phenolic in red wine) has been 
attracting huge attention in the scientific community due to its unquestionable 
great potential [26]. This phenol is mainly present in grapes skin (red ones) 
and seeds. Therefore, because of the removal of the skin and seeds before the 
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fermentation of the white wine, resveratrol is much abundant in red wines as 
compared to the white ones [27]. 
Many studies have been targeting and demonstrating resveratrol promising 
anti-inflammatory properties on immune cells. 
Martinez and Moreno [28] assayed the influence of resveratrol in the 
producing levels of two reactive oxygen species (ROS) species on phorbol 
esters (PMA) or LPS-stimulated murine resident peritoneal macrophages. The 
authors concluded that the levels of superoxide radicals (O2
-
) and hydrogen 
peroxide (H2O2) were significantly reduced. Moreover, they also reported a 
marked decrease of the levels of [
3
H]-arachidonic acid and on COX-2 activity, 
overall resulting in a considerable reduction of the prostaglandin synthesis. 
Furthermore, this stilbene was also shown to suppress the proliferation of 
splenocytes from BALB/c mice, as well as their differentiation into 
macrophages and T- or B- cells. 
Moreover, CD28 and CD80 expressions were notably down-regulated 
while the IL-10 anti-inflammatory cytokine production was stimulated [29]. 
Recently, further assays on LPS-stimulated RAW 264.7 macrophages 
showed more of the resveratrol capacities, namely its ability to not only inhibit 
the NO and TNF-α secretions but also to down-regulate the expression of 
TNF-α, IL-1β, IL-6 and iNOS genes and, more importantly, to inhibit NF-κB 
activation, as also demonstrated in human embryonic kidney cells (HEK-
293T). Since NF-κB is responsible for the expression of several pro-
inflammatory genes, its inhibition contributes to the down-regulation of the 
mentioned genes themselves[30]. 
The intensive research focusing on resveratrol already allow us to 
conclude that its anti-inflammatory effects can occur in distinct inflammatory 
conditions/diseases, affecting the lung, bowel, articulations, brain and 
especially the circulatory system. For example, in an animal model of asthma 
(an obstructive pulmonary disorder caused by an excessive T helper 2 (Th2) 
inflammatory response), the treatment with resveratrol caused the attenuation 
of numerous inflammatory parameters including the reduction of the plasma 
pro-inflammatory cytokines IL-4 and IL-5, airway hyperresponsiveness, 
mucus hypersecretion and eosinophilia [31]. 
Moreover, this stilbene has been compared to the well-known drug 
budesonide, due to their close effects for the reduction of the neutrophil 
recruitment, inhibition of TNF-α, IL-1β, myeloperoxidase (MPO) and cytoki-
ne-induced neutrophil chemoattractant 1 (CINC-1), as demonstrated on LPS-
treated mice. Also, despite Birrell et al. [32] showed a low impact of 
resveratrol in COX-1 or COX-2 gene expression on the lung tissue, a 
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significant reduction on PGE2 levels was registered, suggesting that this 
phenolic can act on other enzymes involved in the prostanoid production 
and/or release. Besides, a study performed with human airway epithelial cells 
concluded that resveratrol interfere with NF-κB activation and COX-2 
expression, as well as with the iNOS expression and the release of the 
cytokines IL-8 and granulo-cyte-macrophage colony-stimulating factor (GM-
CSF), thus impairing the production of new granulocytes [33]. 
Advantages of resveratrol on inflammatory bowel diseases have also been 
described in a study performed in human colon cell lines of Caco-2 and in 
SW480. Once exposed to LPS, both cell lines, previously treated with 
resveratrol, presented a dose-dependent inhibition of iNOS either on mRNA 
and protein expression. Additionally the Toll-like receptor-4 (responsible for 
activation of MAPK signaling pathway) expression was observed to be 
significantly lowered after resveratrol treatment [9]. The authors reported that 
this could be due to the non-activation of the NF-κB, since they observed that 
the phosphorylation of the IκB was impaired [34]. These results are in 
agreement with those reported by Cianciulli et al. [35] whom also described 
the reduction of COX-2 mRNA and protein expression (and consequent 
decreased PGE2 production) on LPS-challenged Caco-2 cells treated with 
resveratrol, as well as its inhibitory effects on IκB phosphorylation and NF-κB 
activation, specifically on IκBα and p65-subunit of NF-κB . 
Regarding rheumatoid arthritis, a systemic autoimmune disease characte-
rized by chronic inflammation of multiple joints resulting in the destruction of 
joint cartilage [36], it was suggested for the first time by Elmali et al. [37] that 
intra-articular injection of resveratrol could protect the cartilage against the 
development of induced arthritis. This hypothesis is corroborated by a recent 
study reporting that collagen-induced arthritis mice treated with resveratrol 
had their inflammatory condition rapidly and significantly reduced after the 
application of a second dose of this stilbene. While exploring these results, it 
was observed that the levels of collagen-specific IgG1 and IgG2a (but not the 
total levels of these IgGs) were markedly reduced compared to the controls, 
suggesting that the resveratrol treatment selectively acts against collagen-
specific B-cells rather than general B-cells. 
Additionally, a relevant reduction of the Th17 cells expression on the 
draining lymph node was also noted and, according to the serum cytokine 
level assessments, the pro-inflammatory cytokines IFN-γ, TNF-α, IL-6, IL-1 
and IL-4 were substantially decreased, while IL-17 expression was practically 
nullified on mice after resveratrol treatment [38]. 
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Resveratrol has also been demonstrated to have an important role in brain 
diseases, particularly affecting the microglia. 
Overall, resveratrol-mediated neuroinflammatory protection can be 
essentially explained by three mechanisms: (1) inhibition of ROS production; 
(2) MAPK signal transduction pathways suppression and (3) suppression of 
the NF-κB signaling pathway activation [39]. 
The main neuronal ROS-production system is NADPH oxidase, which 
contributes to oxidative stress condition and plays a critical role in 
inflammation-induced neurodegeneration. This enzyme has been demonstrated 
to be inhibited by resveratrol resulting in a reduction of ROS levels and 
preventing LPS-challenged microglia from further stimulation and activation 
of the inflammatory MAPK and NF-κB signaling pathways [40]. Moreover 
evidences point that resveratrol can likewise directly interfere with central 
inflammatory molecules, impairing their correct signaling transmission.  
This has been shown by some authors that reported the impairment of the 
MAPK signaling pathway by suppressing the phosphorylation of ERK1/2, p38 
MAPK and JNK, and more importantly, the phosphorylation of IκBα [40-
42].As a result, the production and functioning of pro-inflammatory enzymes 
and mediators including iNOS, COX-2, PGE2, NO, IL-1β, IL-6 and TNF-α are 
hampered by resveratrol, reducing the stimulation and activation of more 
microglial cells and preventing inflammation [43, 44]. 
Finally, resveratrol has been described to exhibit great benefits on 
coronary heart diseases (CHD), in particular in atherosclerosis, that is an artery 
inflammatory disease and also the most relevant CHD. A resume of the 
potential beneficial effects of resveratrol (and other phenolics) in the typical 
cellular events of atherosclerosis is represented in Figure 3. Studies revealed 
that resveratrol antioxidant properties are crucial in preventing the low density 
lipoprotein (LDL) oxidation. This event thus blocks the triggering of the 
endothelial dysfunction and its consequent deregulation of NO production and 
vasoconstriction, as well as the expression of the adhesion molecules and 
further adhesion of the leukocytes to the endothelium [16-18]. Resveratrol has 
been found to up-regulate, in a dose-dependent manner, the endothelial nitric 
oxide synthase (eNOS) mRNA expression on human umbilical vein 
endothelial cells (HUVEC) and their consequent NO production [45] and to 
reduce the adherence of human monocytic cells (THP-1) to the same LPS-
challenged endothelium cell line for more than 50% [46]. To better understand 
these results, resveratrol effect on the expression of E-selectin (primarily 
responsible for the initial monocyte adhesion to endothelium) was evaluated 
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leading to the observation of a significant dose-dependent reduction of the 
adhesion molecule resultant from the suppression of its gene expression [46]. 
Other inflammatory markers are influenced by resveratrol during this 
phase. Csiszar et al. [47] found that resveratrol could also diminish the 
adhesiveness of THP-1 cells to TNF-α- or H2O2-challenged HAEC cells. More 
importantly, the authors reported that in TNF-α-stimulated THP-1 cells, the 
treatment with resveratrol caused a reduction of >50% on the activation of NF-
κB and on the NF-κB-dependent inflammatory markers including iNOS 
synthase, IL-6, ICAM-1 and VCAM. 
On the fatty streak stage of atherosclerosis, the recruited macrophages 
engulf the oxidized LDL (oxLDL) and migrate to the intimal vessel layer [48]. 
At this stage, resveratrol has been shown to be a very effective regulator of 
cholesterol homeostasis having the ability to reduce the cholesterol influx and 
enhance cholesterol efflux of J774 macrophages. 
 
 
Figure 3. Wine and virgin olive oil (VOO)’s phenolic compounds may interfere in 
several steps of atherosclerotic progression. During the first stages of the process, these 
compounds prevent the oxidation of low density lipoprotein cholesterol (LDL) into its 
oxidized form (oxLDL) that in turn will no longer interfere and deregulate endothelium 
function. In an endothelium deregulation scenario, wine and VOO´s compounds 
prevent the over-expression of adhesion molecules (CAMs) as well as the 
macrophages oxLDL uptake, their adhesion to the endothelium and migration to the 
vessel intimal layer. Moreover, wine and VOO´s phenolic compounds may up-regulate 
high density lipoprotein cholesterol (HDL) levels that in turn will interact with the 
lipid laden macrophages in the intimal layer, promoting their cholesterol efflux. 
Besides, by interfering with the pro-inflammatory enzymes and cytokines [inducible 
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nitric oxide synthase (iNOS), monocyte chemoattractant protein (MCP)-1, interleukin 
(IL)-1, IL-6, tumor necrosis factor (TNF)-α, etc.], the compounds may prevent the 
recruitment of other leukocytes, thus blocking the inflammatory progress. On the later 
stages of the inflammation VOO´s phenols play an extremely important protective role 
by inhibiting the expression of several markers [metalloproteinase (MMP)-9, 
cyclooxygenase (COX)-2 and their derivative products such as thromboxanes (TXAs) 
and prostaglandins (PGEs)], and their influence on the atheroma rupture and further 
platelet aggregation upon extravasation. 
Moreover, the oxidative stress induced by Fe/ascorbate ion caused on 
these same macrophages a blockage of apoA-1 (apolipoprotein A-1) and 
HDL3-mediated efflux which was reverted, in a dose-dependent manner, on 
resveratrol-pretreated macrophages [49]. 
 
 
3. VIRGIN OLIVE OIL 
 
Alongside with the red wine, virgin olive oil (VOO) is one of the prime 
ingredients of the MDiet and one of the great contributors for its beneficial 
properties [50]. In fact, VOO is the main source of fat in MDiet, and it has 
been claimed to have several health benefits, particularly those related to CHD 
and atherosclerosis inflammatory processes [51]. 
As VOO results from the first pressings of the olives without using any 
kind of solvents, many of the phenolic compounds present in the fruit (e.g. 
hydroxytyrol, tyrosol, vanillic acid and oleuropein) and their degradation 
compounds are partially drawn within the oil [50]. 
Studies conducted thus far have demonstrated that the VOO´s health 
benefits are mainly associated with its richness in mono and polyunsaturated 
fatty acids (MUFAs and PUFAs, respectively), plus to the oil´s phenolic 
constituents [52]. In fact, phenolics are the VOO´s greatest contributors for its 
anti-inflammatory properties, capable of reducing the expression of pro-infla-
mmatory cytokines, inhibiting the activity of LOX and COX-2, decreasing the 
production of adhesion molecules and eicosanoids derived from arachidonic 
acid and, more importantly, blocking the NF-κB activation [53]. 
From all the VOO´s phenolic compounds, hydroxytyrosol is undoubtedly 
one of the key elements in the regulation of the inflammatory processes [54]. 
In this context, Zhang et al. [54] showed that the exposure of THP-1 cells to 
hydroxytyrosol remarkably suppressed LPS-induced NO production and TNF-
α release. Activities of iNOS and COX-2 plus their corresponding mRNA 
transcription were also inhibited by this phenolic. 
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The latter results are supported by those of Richard et al. [55] whom 
additionally referred that the treatment of LPS-induced RAW 264.7 cells with 
hydroxytyrosol diminished the secretion of cytokines IL-1α, IL-1β, IL-6, IL-
12, TNF-α, the chemokines IFN-γ-induced protein 10 (IP-10), MCP-1 and 
even the gene expression of IL-1α, IP-10, macrophage inflammatory protein 
MIP-1β, matrix metallo-proteinase-9 (MMP-9), and prostaglandin E2 synthase. 
The authors further concluded that these results were, in part, a consequence of 
NF-κB pathway impairment by hydroxytyrosol.In fact, this theory 
corroborates previous studies that linked the hydroxytyrosol anti-inflammatory 
properties to its ability of preventing the NF-κB activation [56]. 
However, hydroxytyrosol is not the only responsible for VOO’s health 
benefits. Visioli et al. [57] reported that both hydroxytyrosol and oleuropein 
were better ROS scavengers and inhibitors of platelet aggregation than 
butylated hydroxytoluene (BHT), which is a well-known commercial 
antioxidant. Furthermore, hydroxytyrosol, oleuropein, caffeic acid, and tyrosol 
were shown to lower leukotriene B4 levels as a result of 5-LOX inhibition on 
rat peritoneal leukocytes [58], while on human blood cultures, the IL-1β or 
PEG2 production were significantly reduced by oleuropein glycoside and 
caffeic acid or by kaempferol, respectively [59]. 
Moreover, similarly to hydroxytyrosol, oleuropein is also able to hamper 
the NF-κB signaling pathway causing the blockage of other inflammatory 
processes dependent on this transcription factor [60]. 
Oleocanthal is one of the VOO’s phenolics that is being target of interest 
in the recent years due to its strong anti-inflammatory capacity. This has a 
mechanism of action closely similar to that of the well-known ibuprofen (a 
strong commercial anti-inflammatory drug), i.e., it negatively interacts on 
prostaglandin and thromboxane biosynthesis throughout inhibition of both 
COX-1 and COX-2. Furthermore, for equimolar concentrations, oleocanthal 
was proven to be even more effective than ibuprofen [50, 61]. 
Because of its particular composition, VOO is a strong edible tool against 
certain diseases as it is the case of inflammatory bowel diseases (IBD) and 
especially atherosclerosis. The latter protection has been closely associated to 
the oil´s phenolic composition. In vivo studies reported that individuals 
submitted to a diet based in phenolic-enriched VOO had their levels of LDL 
decreased while that of HDL were increased, thus improving the lipid efflux 
[49, 62]. 
Once more, hydroxytyrosol and oleuropein play an important role in 
atherosclerosis preventive effects (see general resume in Figure 3), acting on 
the vascular endothelium cells. Indeed, due to their potent antioxidant activity, 
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the two phenolics were shown to prevent endothelial dysfunction of HUVEC 
and pulmonary artery endothelial cells, restraining further ROS production and 
NF-κB activation [63, 64]. Atherosclerosis progress is associated to the 
overexpression of adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in 
order to recruit more leukocytes [65]. However, according to Dell’Agli et al. 
[66], HUVEC cells treated with oleuropein, hydroxytyrosol and homovanillyl 
alcohol demonstrated that the two first polyphenols decreased the expression 
of ICAM-1 and VCAM-1 (surface and mRNA), while homovanillyl alcohol 
reduced the cell surface expression of the three adhesion molecules, despite 
not affecting their mRNA levels. 
Finally, the aforementioned shared ability of hydroxytyrosol and 
oleuropein to restrain MMP-9, COX-2 activity (and consequent eicosanoid 
synthesis) and platelet aggregation is extremely important during the latter 
stages of atherosclerosis, particularly on the arterial thrombosis events which 
are closely related to these markers [54, 67, 68]. 
From the IBD, ulcerative colitis is one of the most common inflammatory 
conditions of the bowel, characterized by a diffuse mucosal inflammation 
limited to the colon [69]. Strong impairment of the bowel inflammation has 
also been correlated to VOO´s phenolic compounds. In mice models of colitis 
submitted to a diet of VOO´s phenolic enriched extracts, it was observed a 
significant decrease of the expression of TNF-α and COX-2, iNOS and MCP-
1, as well as the reduction of IκBα degradation and inactivation of the JNK 
and p38-MAPK, overall resulting in a decreased NF-κB and MAPK signaling 
[70]. In agreement with the later results, Sánchez-Fidalgo et al. [71] reported 
that colitis-induced mice fed with hydroxytyrosol-enriched VOO not only 
reduced iNOS and COX-2 expression and p38-MAPK activation, but also 
enhanced the release of the anti-inflammatory cytokine IL-10, thus suggesting 
that hydroxytyrosol is a key factor in the modulation of this disease. 
Oleuropein anti-inflammatory properties are also associated to bowel 
disease as this was demonstrated to reduce the production of IL-6 and IL-1β, 
and the expression of COX-2 and iNOS, while increasing the IL-10 levels 
[72]. 
Moreover, treatment of colitis mice with oleuropein caused the simulta-
neous reduction of p38-MAPK phosphorylation and NF-κB activation, 
together with a remark stimulation of Annexin A1 production, which is a 
strong endogenous anti-inflammatory agent acting by inhibiting COX-2 and 
iNOS in injured colon tissue [72]. 
Despite these two inflammatory conditions where VOO is clearly 
involved, it is also claimed that the oil exerts beneficial effects in other 
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inflammation-related diseases. It is the case of some cancers where inflamma-
tory conditions have been estimated to contribute in 15-20% for the develop-
ment of phenomena related with all types of cancer [73, 74]. 
The antitumor activity of VOO was demonstrated in ulcerative colitis 
related-carcinogenesis C57BL/6 mice models, that presented a minor number 
of dysplastic macroscopic lesions, accompanied by a reduction of the cytoki-
nes TNF-α, IL-6 and IFN-γ, as well as a decreased expression of COX-2 and 
iNOS in the colonic tissue [75]. 
Again, hydroxytyrosol and oleuropein have been recognized for their cell 
survival modulatory action by mechanisms that include the decreased of 5-
LOX expression, reduced synthesis of prostaglandin E2 and alteration of tumor 
eicosanoid biosynthesis. Also, apoptosis promotion and prevention of oxida-
tive DNA damage have been attributed to these two phenolic compounds as 
concluded from studies in human tumor-cell lines [76, 77]. 
Furthermore, inflammatory angiogenesis, a key element for the tumor 
growth, has been suppressed as a consequence of the MMP-9 down-regulation, 
together with the reduction of ROS and inhibition COX-2 expression in 
cultured endothelial cells treated with both hydroxytyrosol and oleuropein 
[78]. 
Although scarcely studied, some experiments have already been published 
reporting VOO´s neurodegenerative protective effects. According to Pérez-
López et al. [79], consumption of VOO significantly improved learning and 
memory of Alzheimer disease mice models SAMP8. Moreover, oleocanthal 
aforementioned for its COX-1 and COX-2 inhibitory properties, is also able to 
counteract the synapses loss of function and neurofibrillary tangles caused by 
β-amyloid oligomers and of fibrillization of tau-protein, respectively [80-83]. 
Besides, by forming a non-covalent complex with β-amyloid peptide, 
oleuropein can prevent Aβ-aggregation resulting in a decreased deposition of 
these neurotoxic molecules [84]. 
 
 
4. HERBS, VEGETABLES AND FRUITS 
 
The Mediterranean area has a vascular flora of about 25 000 species, both 
in wild or cultivated forms, belonging to distinct families [85]. In this way, 
several plant species are included in MDiet and consumed as vegetables, 
fruits, culinary spices (in flavoring salads, soups, stews and sauces), and herbs 
(e.g. as ingredient of dishes or herbal infusions) [86].Notably, some of them 
have been proposed to act as beneficial agents in inflammatory-related 
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diseases (e.g. atherosclerosis, rheumatoid arthritis, asthma, obesity, diabetes, 
neurodegenerative diseases and even cancer). 
As previously mentioned, chemical in vitro tests for 5-LOX and COX-2 
are routinely used for assessment of anti-inflammatory activities. Based on 
that, Trouillas et al. [87] concluded that from sixteen French hydro-alcoholic 
plants extracts, those obtained from meadowsweet (Filipendula ulmaria), 
lady’s mantle (Alchemilla vulgaris) and rosemary (Rosmarinius officinalis) 
were the most effective in inhibiting LOX, with an IC50 about 0.5 mg/mL. 
In other study, Khasawneh et al. [88] reported a particular low IC50 value 
(1.41 μg/mL) for the inhibition of LOX by a phenolic extract from the aerial 
parts of Leptadenia pyrotechnica, that is a plant traditionally used in Medite-
rranean region in the treatment of a variety of inflammation-related disease. 
The general anti-inflammatory activity of some typical Mediterranean 
plants and fruits have also been accessed in biological models such as the in 
vitro culture cell line leukocytes. Total inhibition of LOX activity was 
registered in rat polymorphonuclear by Prieto and colleagues [89, 90] upon the 
treatment with methanolic extracts of the plant species Cytisus aeolicus (at 200 
μg/ml) and Thymus richardii (at 50 μg/ml). In these experimental conditions, 
the two extracts also significantly inhibited leukotriene B4 production. 
Moreover, other study reported remarkable negative effects of phenolic-
enriched extracts of cinnamon (Cinnamomum zeylanicum), nutmeg (Myristica 
fragrans) and clove (Eugenia aromatica) on COX-2 activity and synthesis of 
prostaglandins [90]. 
Also, the plant species Nigella sativa (i.e. cumin, used in several 
Mediterranean countries for culinary and medicinal purposes) has been shown 
to inhibit nitric oxide release with an IC50 of 6.20 μg/mL, in LPS-stimulated 
macrophage model [91]. For the same biological model, Muller and colleagues 
[92] also concluded that the extracts of Ocimum basilicum (basil) Laurus 
nobilis (bay leaves), Glycyrrhiza glabra (licorice), Origanum onites (oregano), 
Salvia officinalis (sage) and Thymus vulgaris (thyme) could inhibit the 
production of IL-6 or TNF-α and the expression of COX-2 or iNOS, while 
enhancing the production of IL-10. Moreover, the decrement of IL-8 levels 
was documented for H2O2-stimulated human peripheral blood lymphocytes 
(PBLs) co-incubated with uncooked, cooked or digested extracts of important 
ingredients in MedDiet culinary, namely Rosmarinus officinalis, Salvia 
officinalis, and Thymus vulgaris. Part of the anti-inflammatory effects of 
Rosmarinus officinalis and Salvia officinalis were attributed to their content in 
rosmarinic acid, carnosic acid and carnosol [93-95]. 
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Interference of typical Mediterranean fruits on general inflammatory 
mechanistic events has also been reported in distinct biological models and 
further associated to their phenolic composition. In this context, phenolic 
extracts of Capsicum annuum (chili pepper) and Pimenta officinalis (allspice) 
could reduce the production of IL-6, increase the production of IL-10 and 
decrease the expression of COX-2 in a lipopolysaccharide-stimulated macro-
phage model. In turn, Piper nigrum (black pepper) and Myristica fragrans 
(nutmeg) phenolic extracts reduced the expression of COX-2 and the produc-
tion of IL-6 or TNF-α in the same experimental model. 
With exception of the latter species, the remaining could inhibit the 
expression of iNOS [92]. Also, phenolic extracts of apple (Malus domestica 
Borkh) were described to reduce the production of IL-6 and the expression of 
COX-2 in the previous cellular model [96]. 
Paw edema induced by carrageenan, histamine, dextran and ear edema 
induced by toxics as croton oil, arachidonic-acid and xylene [97-100] are 
major in vivo models for assessing inflammatory actions of plant and/or fruit 
extracts. 
In this way, distinct extracts of Lamium plants, namely L. garganicum 
subsp. laevigatum, L. garganicum subsp. pulchrum and L. purpureum var. 
purpureum have demonstrated good anti-inflammatory activities in carra-
geenan-induced paw edema model, causing a reduction of the edema of appro-
ximately 12 to 30% [101]. Furthermore, in the same in vivo model, Lee and 
colleagues [102] showed that an hydroethanolic extract of Leonurus sibiricus 
(siberian motherwort) could suppress the activation of inflammatory media-
tors. 
In turn, inhibition of the croton oil-induced ear edema in mice model was 
used to evaluate topical anti-inflammatory activity of several dietary 
Mediterranean plants such as Malva sylvestris (Mallow), Borago officinalis 
(Borage), Capparis sicula (Caper), Raphanus raphanistrum (Radish) and 
Mentha aquatica (water mint). These plants are traditionally used in local 
medicine for the treatment of external inflammation and inflammation-related 
diseases. Overall, the hydroethanolic extracts of the cited plant species 
provided an inhibition of 21 to 27%, with the best result being obtained for 
water mint, in accordance to its best antioxidant activity on DPPH scavenging 
and lipid peroxidation tests [103]. Also, hydroalcoholic extracts of the edible 
plants Cichorium intybus L. (chicory), Papaver rhoeas L. (poppy), Lepidium 
sativum L. (cress) and Echium vulgare L. (viper’s Bugloss) provided 18% to 
43% of edema reduction in the same model [104]. 
Mediterranean Diet: A Way of Fighting Inflammatory Diseases 21 
Similarly, an extract obtained from the species Bear's Breech (Acanthus 
montanus) i.e., a shrub widespread in Balkans, Romania, Greece, Eastern 
Mediterranean and Africa, has been reported to effectively inhibit (57%) 
topical acute edema in the mouse ear-edema model and to suppress the 
development of acute edema of the rat paw-edema model, in a non-dose-
related manner. The same study also showed that the extract could inhibit 
vascular permeability and the haemolysis of red blood cells [105].  
The documented anti-inflammatory effects of typical Mediterranean fruits 
in in vivo models are scarce. Still, important data has been described for 
Punica granatum L. (pomegranate), which is commonly consumed in 
Mediterranean diet and used as therapeutic and cosmetic agent.In fact, besides 
its capacity of reducing NO levels in macrophages, this fruit was shown to 
decrease carrageenan-induced mice paw edema [106]. The authors have 
attributed the anti-inflammatory effects of the extract to the hydrolysable 
tannins punicalagin, punicalin, strictinin and specially granatin B [106]. 
Moreover, tests performed by Shukla and colleagues [107] showed that the 
plasma sample obtained after oral administration of a polyphenol rich extract 
of pomegranate in rabbits inhibited the activity of COX-2. Similar conditions 
also reduced IL-1β-induced PGE2 and NO production in a rabbit chondrocytes 
cellular model. 
Although still rare, studies performed in more specific models suggest that 
some of the Mediterranean diet components can counteract inflammatory-
related diseases. This is the case of a Rosmarinus officinalis phenolic extract, 
which has been shown to exert potent anti-inflammatory effects (preventing 
swelling and decreasing the infiltration of neutrophils) in rat ethanol-induced 
gastric ulcer model [108]. Additionally, in a pleurisy-mouse model induced by 
carrageenan, phenolic extracts of Rosmarinus officinalis inhibited leukocytes 
and exudation, as well as the pro-inflammatory enzyme myeloperoxidase 
(MPO) and the levels of nitrite/nitrate, IL-1β and TNF-α [109]. Even more, an 
antiatherosclerotic effect has also been associated to Rosmarinus officinalis-
phenolic extracts due to its ability in counteracting the migration of vascular 
smooth muscle cells and to decrease MMP-9 and MCP-1 expressions. In this 
case, the benefits were associated by the authors to the presence of carnosic 
acid [110]. Plus, the intestinal anti-inflammatoy effect of hydroalcoholic 
extracts of Phlomis lychnitis and Phlomis purpurea was observed by Algieri 
and colleagues in a trinitrobenze-nesulphonic acid (TNBS) model of rat colitis, 
i.e. an experimental model of the human inflammatory bowel disease [111]. 
Protective effects of phenolic extracts on inflammatory-associated cancer 
conditions were suggested for six native Mediterranean herbs. Specifically, the 
Marcelo D. Catarino, Jorge M. Alves-Silva, Olívia R. Pereira et al. 22 
treatment of TNF-α-stimulated epithelial colon cancer (HT29) and prostate 
cancer (PC3) cells with herbal infusions of Cretan marjoram (Origanum 
microphyllum), oregano (O. vulgare), pink savory (Satureja thymbra), 
mountain tea (Sideritis syriaca), pennyroyal (Mentha pulegium) or chamomile 
(Matricaria chamomilla) significantly reduced the cellular IL-8 levels. Also, 
infusions of the latter plant species could reduce the levels of NF-κB p65-
subunit in HT29 cells [112]. 
Protective effects of fruit phenolic extracts on specific inflammatory-
disease models were also reported. Accordingly, a methanolic extract of date 
fruit (Phoenix dactylifera L.) was evaluated in an adjuvant arthritis in rats, a 
model of chronic inflammation. The results indicated that the extract could 
ameliorate the plasma antioxidant state (i.e. decreased the levels of lipid 
peroxides while increase the levels of vitamin C, E, A and β-carotene) and 
reduce foot swelling by approximately 68%. Additionally in this model, the 
extract exposure caused a reduction on the activity of COX-1 and COX-2 by 
about 30 and 50%, respectively [113, 114]. 
Moreover, the positive effects of a methanolic extract of pomegranate on 
gastric inflammation has been shown to reduce the ulcer index (UI) and the 
intraluminal bleeding in ethanol-induced gastritis in rats. Furthermore, the 
extract treatment induced the decrement of TNF-α levels, while the reduction 
of several inflammatory protein levels (e.g. IL-4, IL-6, IL-1β, IL-10) were 
observed in an acetic acid-induced ulcer model [115]. Similar protective 
effects have been demonstrated in intestinal models [116]. 
Several studies indicate that strawberry, i.e. Fragaria x ananassa Duch 
possess anti-inflammatory effects that are commonly associated to the fruit´s 
ellagitannin content [117, 118]. Concretely, strawberry fruit juice has been 
shown to interfere in cytokine secretion ratios as demonstrated in murine 
primary splenocytes and peritoneal macrophages models [119]. 
Besides to the antioxidant activities demonstrated, strawberry extracts 
could reduce, in a dose-dependent manner, the induced activator protein-1 
(AP-1) and the NF-κB activity induced by UVB or tetradecanoylphorbol-13-
acetate (TPA) in JB6 P+ mouse epidermal cells, thus suggesting a chemopre-
ventive effect [120]. 
Cardile and colleagues have concluded that the dose-dependent anti-
inflammatory effect of red orange (Citrus sinensis) on a human keratinocyte 
line NCTC 2544 exposed to IFN-γ and histamine was due to the decrement on 
the expression of ICAM-1, monocyte chemoattractant protein-1 (MCP-1) and 
IL-8 [121]. 
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Additionally, a phenolic extract of orange was reported to induce positive 
effects on endothelial function, mediated by the decrement of high-sensitivity 
C-reactive protein, TNF-α and IL-6 [122]. 
 
 
CONCLUSION 
 
Mediterranean diet, characteristic of Mediterranean basin located 
countries like Portugal, Spain, Croatia, Cyprus, Greece, Italy and Morocco is 
claimed to be associated with several health benefits, including the anti-infla-
mmatory. 
In part, this is because MDiet includes a wide range of fruits and 
vegetables, as well as fruit derivative products, such as wine and virgin olive 
oil, which are particularly enriched in polyphenols of proven anti-
inflammatory properties. 
The anti-inflammatory activities of phenolic compounds include the inhi-
bition of NF-κB activation, together with the expression decrement of cyto-
kines and chemokines, LOX and COX-2 enzymes, with concomitant lowering 
levels of prostaglandins, leukotrienes and thromboxanes. Other mechanism 
includes the decrease of intracellular oxidative stress. 
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